Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07296991

VR Stimulation of Exercise Response in Sedentary Humans

Prolonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit fly model, genetic stimulation of neurons that promote adrenergic signaling is sufficient to mimic the benefits of exercise training even in sedentary animals. The investigator's pilot work in humans has confirmed that humans respond to Virtual Reality (VR) stimuli that mimic exercise by increasing heart rate and altering heart rate variability in a way consistent with increased adrenergic activity.

In this study, the investigators will directly test for the first time whether repeated, controlled exposure to VR stimuli that induce adrenergic activity in sedentary humans can produce adaptive changes to protein expression and endurance performance like those produced by actual exercise in pre-diabetic participants with/without hypertension.

Recruiting

Interested in participating?

Request Info

Key information

Age range

25 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Equal numbers male and female (32 each)
  • Blood glucose HbA1C: 5.7-6.4% or 100-125 mg/dL
  • BP: systolic<120 and diastolic<80 mmHg, systolic 120-129 mmHg and diastolic <80 mmHg, or systolic >130 mmHg and diastolic >80 mmHg

Exclusion criteria

  • BMI>35kg/m2
  • Currently involved in an exercise program or similar activity
  • Taking medications that could affect results, including beta-blockers or SSRIs
  • Demonstrate any form of discomfort with the VR experience through self-reported feelings of anxiety or nausea
  • Alcohol consumption above a minimal level(<2 oz/night)
  • BP: Systolic >160 mmHg and Diastolic >110 mmHg

Treatment and study plan

20 minutes cycling exercise

Behavioral

20 minutes cycling exercise

Virtual reality

Behavioral

20 minutes virtual cycling

Primary outcomes

  1. Blood Glucose, HbA1C

    Time frame: 10 weeks

    Pre-diabetic patients (Blood glucose 100-125 mg/dL, AbA1C 5.7-6.4%) may see improvement in values post-intervention

Secondary outcomes

  1. 10 minute walk time

    Time frame: 10 weeks

    distance walked in 10 minutes is recorded pre- and post- intervention and may improve

Study contacts

Contact information is provided by the study sponsor or research team.

Alyson Sujkowski, PhD

CONTACT

[email protected]

419-461-4317

Robert J Wessells, PhD

CONTACT

7344764325

Sponsors and collaborators

Lead sponsor

Wayne State University

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Dec 22, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.